(2023)
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
21
(2023)
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
7
(2023)
Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer.
FRONTIERS IN ONCOLOGY.
13,
(2022)
Histologic analysis according to HER2 gene status in HER2 2 + invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations.
VIRCHOWS ARCHIV.
480,
4
(2022)
Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer.
NPJ BREAST CANCER.
8,
1
(2021)
A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE.
55,
6
(2021)
Elevated level of nerve growth factor (Ngf) in serum-derived exosomes predicts poor survival in patients with breast cancer undergoing neoadjuvant chemotherapy.
CANCERS.
13,
21
(2021)
Distribution of tumor subtypes in bilateral breast cancer: Comparison between synchronous and metachronous cancer.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY.
(2021)
Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer.
BREAST CANCER RESEARCH AND TREATMENT.
189,
3
(2021)
Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients.
SCIENTIFIC REPORTS.
11,
1
(2021)
Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability.
JOURNAL OF BREAST CANCER.
24,
3
(2021)
Metformin reduces histone h3k4me3 at the promoter regions of positive cell cycle regulatory genes in lung cancer cells.
CANCERS.
13,
4
(2020)
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer.
BREAST CANCER RESEARCH AND TREATMENT.
184,
2
(2020)
Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer.
JOURNAL OF CLINICAL MEDICINE.
9,
10
(2020)
Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.
DIAGNOSTIC PATHOLOGY.
15,
1
(2020)
Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology.
ANTICANCER RESEARCH.
40,
5
(2020)
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast.
Journal of Pathology and Translational Medicine.
54,
1
(2020)
Lymphomatoid granulomatosis involving the lung and brain in a child: A case report.
Journal of the Korean Society of Radiology.
82,
(2019)
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
BREAST CANCER RESEARCH AND TREATMENT.
176,
1
단행본
(2014)
유방병리 입문.
페이지원 단행본 출판팀.
공동
학술회의논문
(2010)
DNA Methylation of Integrin α4 and Clinicopathological Correlation in Breast Cancer.
대한병리학회 가을학술대회.
대한민국
(2010)
Immunohistochemical demonstration of cyclin A2, cyclin D1, p15 and cytochrome C.
대한병리학회 가을학술대회.
대한민국
